Talal Alzahrani1, Ivan Pena1, Nardos Temesgen1, Stanton A Glantz2. 1. Department of Medicine, George Washington University, Washington, District of Columbia. 2. Department of Medicine, Cardiovascular Research Institute, Philip R. Lee Institute for Health Policy Studies, Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California. Electronic address: stanton.glantz@ucsf.edu.
Abstract
INTRODUCTION: Electronic cigarettes (e-cigarettes) are promoted as a less risky alternative to conventional cigarettes and have grown in popularity. Experimental and clinical evidence suggests that they could increase the risk of myocardial infarction. METHODS: The National Health Interview Surveys of 2014 (n=36,697) and 2016 (n=33,028) were used to examine the cross-sectional association between e-cigarette use (never, former, some days, daily) and cigarette smoking (same categories) and myocardial infarction in a single logistic regression model that also included demographics (age, gender, BMI) and health characteristics (hypertension, diabetes, and hypercholesterolemia) using logistic regression. Data were collected in 2014 and 2016 and analyzed in 2017 and 2018. RESULTS: Daily e-cigarette use was independently associated with increased odds of having had a myocardial infarction (OR=1.79, 95% CI=1.20, 2.66, p=0.004) as was daily conventional cigarette smoking (OR=2.72, 95% CI=2.29, 3.24, p<0.001). Former and some day e-cigarette use were not significantly associated with having had a myocardial infarction (p=0.608 and p=0.392) whereas former (OR=1.70, p<0.001) and some day cigarette smoking (OR=2.36, p<0.001) were. Odds of a myocardial infarction were also increased with history of hypertension (OR=2.32, p<0.001); high cholesterol (OR=2.36, p<0.001); and diabetes (OR=1.77, p<0.001); and age (OR=1.65 per 10 years, p<0.001). Women (OR=0.47, p<0.001) had lower odds of myocardial infarction. CONCLUSIONS: Daily e-cigarette use, adjusted for smoking conventional cigarettes as well as other risk factors, is associated with increased risk of myocardial infarction.
INTRODUCTION: Electronic cigarettes (e-cigarettes) are promoted as a less risky alternative to conventional cigarettes and have grown in popularity. Experimental and clinical evidence suggests that they could increase the risk of myocardial infarction. METHODS: The National Health Interview Surveys of 2014 (n=36,697) and 2016 (n=33,028) were used to examine the cross-sectional association between e-cigarette use (never, former, some days, daily) and cigarette smoking (same categories) and myocardial infarction in a single logistic regression model that also included demographics (age, gender, BMI) and health characteristics (hypertension, diabetes, and hypercholesterolemia) using logistic regression. Data were collected in 2014 and 2016 and analyzed in 2017 and 2018. RESULTS: Daily e-cigarette use was independently associated with increased odds of having had a myocardial infarction (OR=1.79, 95% CI=1.20, 2.66, p=0.004) as was daily conventional cigarette smoking (OR=2.72, 95% CI=2.29, 3.24, p<0.001). Former and some day e-cigarette use were not significantly associated with having had a myocardial infarction (p=0.608 and p=0.392) whereas former (OR=1.70, p<0.001) and some day cigarette smoking (OR=2.36, p<0.001) were. Odds of a myocardial infarction were also increased with history of hypertension (OR=2.32, p<0.001); high cholesterol (OR=2.36, p<0.001); and diabetes (OR=1.77, p<0.001); and age (OR=1.65 per 10 years, p<0.001). Women (OR=0.47, p<0.001) had lower odds of myocardial infarction. CONCLUSIONS: Daily e-cigarette use, adjusted for smoking conventional cigarettes as well as other risk factors, is associated with increased risk of myocardial infarction.
Authors: Robert D Brook; Robert L Bard; Richard T Burnett; Hwashin H Shin; Alan Vette; Carry Croghan; Michael Phillips; Charles Rodes; Jonathan Thornburg; Ron Williams Journal: Occup Environ Med Date: 2010-10-08 Impact factor: 4.402
Authors: Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer Journal: J Clin Epidemiol Date: 2004-10 Impact factor: 6.437
Authors: Paul V Targonski; Piero O Bonetti; Geralyn M Pumper; Stuart T Higano; David R Holmes; Amir Lerman Journal: Circulation Date: 2003-05-27 Impact factor: 29.690
Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552
Authors: Andrew Higham; Nicholas J W Rattray; Jennifer A Dewhurst; Drupad K Trivedi; Stephen J Fowler; Royston Goodacre; Dave Singh Journal: Respir Res Date: 2016-05-17
Authors: Jorge Espinoza-Derout; Kamrul M Hasan; Xuesi M Shao; Maria C Jordan; Carl Sims; Desean L Lee; Satyesh Sinha; Zena Simmons; Norma Mtume; Yanjun Liu; Kenneth P Roos; Amiya P Sinha-Hikim; Theodore C Friedman Journal: Am J Physiol Heart Circ Physiol Date: 2019-06-07 Impact factor: 4.733
Authors: Godfred O Antwi; David K Lohrmann; Wasantha Jayawardene; Angela Chow; Cecilia S Obeng; Aaron M Sayegh Journal: J Cancer Surviv Date: 2019-04-06 Impact factor: 4.442
Authors: Nicholas D Buchanan; Jacob A Grimmer; Vineeta Tanwar; Neill Schwieterman; Peter J Mohler; Loren E Wold Journal: Cardiovasc Res Date: 2020-01-01 Impact factor: 10.787
Authors: Cara Lea Smith; Matthew Seigerman; Srinath Adusumalli; Jay Giri; Paul N Fiorilli; Daniel M Kolansky; Taisei Kobayashi Journal: Curr Cardiol Rep Date: 2021-03-08 Impact factor: 2.931